Free Trial
OTCMKTS:PKTX

ProtoKinetix (PKTX) Stock Price, News & Analysis

ProtoKinetix logo
$0.0090 +0.00 (+3.45%)
As of 05/30/2025 10:44 AM Eastern

About ProtoKinetix Stock (OTCMKTS:PKTX)

Key Stats

Today's Range
$0.0084
$0.0090
50-Day Range
$0.0081
$0.0141
52-Week Range
$0.0080
$0.0153
Volume
66,550 shs
Average Volume
119,899 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

ProtoKinetix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

PKTX MarketRank™: 

ProtoKinetix scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for ProtoKinetix.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ProtoKinetix is -4.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ProtoKinetix is -4.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    ProtoKinetix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProtoKinetix has recently decreased by 90.09%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ProtoKinetix does not currently pay a dividend.

  • Dividend Growth

    ProtoKinetix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    ProtoKinetix has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ProtoKinetix has recently decreased by 90.09%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ProtoKinetix has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ProtoKinetix this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, ProtoKinetix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.87% of the stock of ProtoKinetix is held by insiders.

  • Percentage Held by Institutions

    Only 0.04% of the stock of ProtoKinetix is held by institutions.

  • Read more about ProtoKinetix's insider trading history.
Receive PKTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProtoKinetix and its competitors with MarketBeat's FREE daily newsletter.

PKTX Stock News Headlines

Protokinetix Inc
FNAM Evolutionary Genomics, Inc.
The Social Security Changes No One’s Talking About
While most Americans worry about their next Social Security check... something far bigger is happening behind the scenes. An AI plan — authorized by Executive Order — is about to rewrite how the SSA operates.
Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying
ProtoKinetix, Incorporated (PKTX)
ProtoKinetix Inc PKTX
See More Headlines

PKTX Stock Analysis - Frequently Asked Questions

ProtoKinetix's stock was trading at $0.01 at the beginning of the year. Since then, PKTX shares have decreased by 10.0% and is now trading at $0.0090.
View the best growth stocks for 2025 here
.

Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProtoKinetix investors own include Sangamo Therapeutics (SGMO), Abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), MSP Recovery (LIFW), Fulcrum Therapeutics (FULC), NVIDIA (NVDA) and Tenax Therapeutics (TENX).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PKTX
Previous Symbol
NASDAQ:PKTX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:PKTX) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners